CannTrust Holdings Inc is a Canada-based company, which produces pharmaceutical-grade medical cannabis for patients. The Company is a federally regulated licensed producer of medical cannabis products. The Company operates a hydroponic facility and an onsite laboratory for testing and research on the medical use of cannabis. The Company's exclusive pharmaceutical partner is Apotex. CannTrust Holdings Inc's products are divided into the following: Products Type, such as oil, dried cannabis, accessories and patient ready; Strain Type, such as hybrid, sativa dominant and indica dominant, as well as Strength, such as strong, mild and moderate. The Company's products are sold online through its Website.
Industry, Sector and Symbol
Stock Exchange CNSX
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCNSX:TRST
CUSIPN/A
Phone+1-647-8722300
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins10.67%
Return on Equity6.25%
Return on Assets5.34%
Miscellaneous
EmployeesN/A
Outstanding Shares86,860,000
Market CapC$793.59
CannTrust (CNSX:TRST) Frequently Asked Questions
What is CannTrust's stock symbol?
CannTrust trades on the CNSX under the ticker symbol "TRST."
What price target have analysts set for TRST?
0 equities research analysts have issued 12-month price targets for CannTrust's stock. Their forecasts range from C$9.50 to C$13.00. On average, they anticipate CannTrust's share price to reach C$11.25 in the next year. This suggests a possible upside of 25.0% from the stock's current price. View Analyst Ratings for CannTrust.
What is the consensus analysts' recommendation for CannTrust?
0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."
Has CannTrust been receiving favorable news coverage?
Media stories about TRST stock have been trending somewhat positive this week, Accern reports. The research firm scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. CannTrust earned a media sentiment score of 0.08 on Accern's scale. They also gave news articles about the company an impact score of 46.31 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
What is CannTrust's stock price today?
One share of TRST stock can currently be purchased for approximately C$9.00.
How big of a company is CannTrust?
CannTrust has a market capitalization of C$793.59 million.
How can I contact CannTrust?
CannTrust's mailing address is 3280 Langstaff Rd Unit 1, CONCORD, ON L4K 4Z8, Canada. The company can be reached via phone at +1-647-8722300.
MarketBeat Community Rating for CannTrust (CNSX TRST)
MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote "Outperform" if you believe TRST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRST will underperform the S&P 500 over the long term. You may vote once every thirty days.
